Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$101.21 - $166.61 $1.58 Million - $2.61 Million
15,660 New
15,660 $1.86 Million
Q4 2022

Jan 25, 2023

BUY
$118.38 - $210.04 $473,520 - $840,160
4,000 New
4,000 $0
Q4 2020

Feb 08, 2021

SELL
$65.74 - $169.86 $788,879 - $2.04 Million
-12,000 Closed
0 $0
Q3 2020

Nov 09, 2020

BUY
$54.34 - $94.85 $652,080 - $1.14 Million
12,000 New
12,000 $850,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.